Surgery for Testicular Cancer

  • Gillian L. Smith
  • Timothy J. Christmas


Testicular germ cell tumors are highly curable, even when metastatic at presentation. Although this is largely because of their sensitivity to platinum-based chemotherapy, well-timed surgical intervention is also crucial in achieving a high cure rate. The diagnosis is usually established by inguinal orchidectomy, and orchidectomy alone represents adequate treatment for many patients. Operative removal of metastatic disease, usually after chemotherapy, is also highly effective and may be curative. Thus the importance of surgical treatment for testicular cancer should not be underestimated.


Inferior Vena Cava Testicular Cancer Testis Cancer Urologic Cancer Nonseminomatous Germ Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Capelouto CC, Clark PE, Ransil BJ, Loughlin KR. A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary? J Urol 1995;153:981–985.PubMedCrossRefGoogle Scholar
  2. 2.
    Barrett DM, O’Sullivan DC, Malizia AA, et al. Particle shedding and migration from silicone genitourinary prosthetic devices. J Urol 1991;146:319–322.PubMedGoogle Scholar
  3. 3.
    Henderson J, Culkin D, Mata J, Wilson M, Venable D. Analysis of immunological alterations associated with testicular prostheses. J Urol 1995;154:1748–1751.PubMedCrossRefGoogle Scholar
  4. 4.
    Adshead J, Khoubehi B, Wood J, Rustin G. Testicular implants and patient satisfaction: a questionnaire-based study of men after orchidectomy for testicular cancer. BJU Int 2001;88(6):559–562.PubMedCrossRefGoogle Scholar
  5. 5.
    Incrocci L, Bosch JL, Slob AK. Testicular prostheses: body image and sexual functioning. BJU Int 1999;84(9):1043–1045.PubMedCrossRefGoogle Scholar
  6. 6.
    Heidenreich A, Albers P, Hartmann M, Kliesch S, Kohrmann KU, Dleckmann KP, German Testicular Cancer Study Group. Organ sparing surgery for malignant germ cell tumor of the testis. J Urol 2001;166:2161–2165.PubMedCrossRefGoogle Scholar
  7. 7.
    Skakkebaek NE. Possible carcinoma-in-situ of testis. Lancet 1992;2(7776):516–517.Google Scholar
  8. 8.
    Skakkebaek NE, Rajpert-De Meyts E, Jorgensen N, et al. Germ cell cancer and disorders of spermatogenesis: an environmental connection? Acta Pathol Microbial Scand 1998;106:3–11.Google Scholar
  9. 9.
    Bettocchi C, Coker CB, Deacon J, Parkinson C, Pryor JP. A review of testicular intratubular germ cell neoplasia in infertile men. J Androl 1994;15(suppl):14S–16S.PubMedGoogle Scholar
  10. 10.
    Montironi R. Intratubular germ cell neoplasia of the testis: testicular intraepithelial neoplasia. Eur Urol 2002;41:651–654.PubMedCrossRefGoogle Scholar
  11. 11.
    Harland S, Cook PA, Fossa SD, et al. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: defining a high risk group. J Urol 1998;16:1353–1357.Google Scholar
  12. 12.
    Stimson JC. A new operation for malignant tumors of the testicle. The necessity of a more extensive operation than castration for carcinoma, sarcoma of the testicle. Medical Record 1897;52:623.Google Scholar
  13. 13.
    Roberts JB. Excision of the lumbar lymph nodes and spermatic vein in malignant tumors of the testicle. Am J Surg 1902;36:539.Google Scholar
  14. 14.
    Bland-Sutton J. An operation for lumbar gland removal in cases of testis tumour. Lancet 1909;1:1406.Google Scholar
  15. 15.
    Ray B, Hajdu SI, Whitmore WF. Distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer 1973;33:340–348.CrossRefGoogle Scholar
  16. 16.
    Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol 1982;128:315–320.PubMedGoogle Scholar
  17. 17.
    Hendry WF. Decision making in abdominal surgery following chemotherapy for testicular cancer. Eur J Cancer 1995;5:649–650.CrossRefGoogle Scholar
  18. 18.
    Nichols CR, Saxman S. Primary salvage treatment of recurrent germ cell tumors: experience at Indiana University. Semin Oncol 1998;25:210–214.PubMedGoogle Scholar
  19. 19.
    Donohue JP, Thornhill JA, Foster RS, et al. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. J Urol 1993;149:237–243.PubMedGoogle Scholar
  20. 20.
    Foster RS, Donohue JP. Surgical treatment of clinical stage A nonseminomatous testis cancer. Semin Oncol 1992;19:166–170.PubMedGoogle Scholar
  21. 21.
    Foster RS, Donohue JP. Nerve-sparing retroperitoneal lymphadenectomy. Urol Clin North Am 1993;20:117–125.PubMedGoogle Scholar
  22. 22.
    Bower M, Ma R, Savage P, et al. British urological surgery practice: 2. Renal, bladder and testis cancer. Br J Urol 1998;81:513–517.PubMedGoogle Scholar
  23. 23.
    Foster RS, McNulty A, Rubin LR, et al. The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection [see comments]. J Urol 1994;152:1139–1142.PubMedGoogle Scholar
  24. 24.
    Donohue JP, Thornhill JA, Foster RS, et al. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989). J Urol 1995;153:85–89.PubMedCrossRefGoogle Scholar
  25. 25.
    Baniel J, Sella A. Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post-chemotherapy. Semin Surg Oncol 1999;17(4):263–267.PubMedCrossRefGoogle Scholar
  26. 26.
    Tait D, Peckham MJ, Hendry WF, Goldstraw P. Post-chemotherapy surgery in advanced non-seminomatous germ cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer 1984;50:601–609.PubMedGoogle Scholar
  27. 27.
    Hendry WF, A’Hern RP, Hetherington JW, et al. Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. Br J Urol 1993;71:208–213.PubMedCrossRefGoogle Scholar
  28. 28.
    Janetschek G, Hobisch A, Hittmair A, et al. Laparoscopic retroperitoneal lymphadenectomy after chemotherapy for stage IIB nonseminomatous testicular carcinoma. J Urol 1999;161:477–481.PubMedCrossRefGoogle Scholar
  29. 29.
    Napier MP, Naraghi A, Christmas TJ, Rustin GJ. Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours. Br J Cancer 2000;83:1274–1280.PubMedCrossRefGoogle Scholar
  30. 30.
    Christmas TJ, Smith GL, Kooner RS. Reoperation for metastatic testis cancer after chemotherapy. J Urol 1998;159(suppl):49.Google Scholar
  31. 31.
    Ravi R, Ong J, Oiver RT, et al. Surgery as salvage therapy in chemotherapy-resistant nonseminomatous germ cell tumours. Br J Urol 1998;81:884–888.PubMedGoogle Scholar
  32. 32.
    Elkabir JJ, Christmas TJ, Ellamushi H, Mendoza N. Late relapse of metastatic teratoma invading a vertebral body: a combined surgical approach. Br J Urol 1997;79:999–1000.PubMedGoogle Scholar
  33. 33.
    Mosharafa AA, Foster RS, Leibovich BC, Bihrle R, Johnson C, Donohue JP. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity? J Urol 2003;169:2126–2128.PubMedCrossRefGoogle Scholar
  34. 34.
    Mosharafa AA, Foster RS, Bihrle R, et al. Does retroperitoneal lymph node dissection have a curative role for patients with sex cordstromal testicular tumors? Cancer 2003;98(4):753–757.PubMedCrossRefGoogle Scholar
  35. 35.
    Smith GL, Christmas TJ, Seckl MJ, Rustin GJS. The role of retroperitoneal lymph node dissection in the management of stromal tumours of the testis. BJU Int 2003;91(suppl):61.Google Scholar
  36. 36.
    Peschel R, Gettman MT, Steiner H, Neururer R, Bartsch G. Management of adult Leydig-cell testicular tumors: assessing the role of laparoscopic retroperitoneal lymph node dissection. J Endourol 2003;17:777–780.PubMedCrossRefGoogle Scholar
  37. 37.
    Christmas TJ, Smith GL, Kooner RS. Wedge resection of pulmonary metastases from cancer of the testis or kidney using a vascular staple device. Br J Urol 1998;81(6):911–912.PubMedGoogle Scholar
  38. 38.
    Christmas TJ, Doherty AP, Bower M. Retrocrural lymph node metastases from testis germ cell tumours: removal via a thoracoabdominal extraperitoneal approach after chemotherapy. Br J Urol 1997;79(3):468–470.PubMedGoogle Scholar
  39. 39.
    Leiter E, Brendler H. Loss of ejaculation following bilateral retroperitoneal lymphadenectomy. J Urol 1967;98:375–378.PubMedGoogle Scholar
  40. 40.
    Donohue JP, Foster RS, Rowland RG, et al. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 1990;144:287–291.PubMedGoogle Scholar
  41. 41.
    Nash PA, Leibovitch I, Foster RS, et al. En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes. J Urol 1998;159:707–710.PubMedCrossRefGoogle Scholar
  42. 42.
    Christmas TJ, Smith GL, Kooner R. Vascular interventions during post-chemotherapy retroperitoneal lymph-node dissection for metastatic testis cancer. Eur J Surg Oncol 1998;24(4):292–297.PubMedCrossRefGoogle Scholar
  43. 43.
    Baniel J, Foster RS, Rowland RG, et al. Complications of postchemotherapy retroperitoneal lymph node dissection. J Urol 1995;153:976–980.PubMedCrossRefGoogle Scholar
  44. 44.
    Heidenreich, A, Albers P, Hartmann M, et al., German Testicular Cancer Study Group. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol 2003;169:1710–1714.PubMedCrossRefGoogle Scholar
  45. 45.
    Mosharafa AA, Foster RS, Koch MO, Bihrle R, Donohue JP. Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol 2004;171:1839–1841.PubMedCrossRefGoogle Scholar
  46. 46.
    Christmas TJ, Doherty AP, Rustin HJ, et al. Excision of residual masses of metastatic germ cell tumours after chemotherapy: the role of extra-peritoneal surgical approaches. Br J Urol 1998;81:301–308.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2007

Authors and Affiliations

  • Gillian L. Smith
    • 1
  • Timothy J. Christmas
    • 2
  1. 1.Department of UrologyThe Royal Free HospitalLondonUK
  2. 2.Department of Urology Imperial College School of MedicineCharing Cross HospitalLondonUK

Personalised recommendations